ABCG2 and breast cancer: Topotecan selected drug resistance was found related to expression and efflux activity of ABCG2 expression in human breast cancer cells (Yang et al., 2000) or overexpression of both ABCG2 and ABCB1 transporters in human ovarian cancer cells (Januchowski et al., 2016).